BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23270509)

  • 1. Impact of pharmaceutical care on the quality of life of patients with Chagas disease and heart failure: randomized clinical trial.
    Sperandio da Silva GM; Chambela MC; Sousa AS; Sangenis LH; Xavier SS; Costa AR; Brasil PE; Hasslocher-Moreno AM; Saraiva RM
    Trials; 2012 Dec; 13():244. PubMed ID: 23270509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of physical exercise training in patients with Chagas heart disease: study protocol for a randomized controlled trial (PEACH study).
    Mendes Fde S; Sousa AS; Souza FC; Pinto VL; Silva PS; Saraiva RM; Xavier SS; Veloso HH; Holanda MT; Costa AR; Carneiro FM; Silva GM; Borges JP; Tibirica E; Pinheiro RO; Lara FA; Hasslocher-Moreno AM; Brasil PE; Mediano MF
    Trials; 2016 Sep; 17(1):433. PubMed ID: 27590681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An intervention to promote physical activity and self-management in people with stable chronic heart failure The Home-Heart-Walk study: study protocol for a randomized controlled trial.
    Du HY; Newton PJ; Zecchin R; Denniss R; Salamonson Y; Everett B; Currow DC; Macdonald PS; Davidson PM
    Trials; 2011 Mar; 12():63. PubMed ID: 21366927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of Qishen granules in patients with chronic heart failure: study protocol for a randomized controlled trial.
    Wang J; Shi J; Wei J; Wang J; Gao K; Li X; Chen J; Li S; Zhao H; Wang W
    Trials; 2017 Oct; 18(1):468. PubMed ID: 29017565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selenium Treatment and Chagasic Cardiopathy (STCC): study protocol for a double-blind randomized controlled trial.
    Alvarenga Americano do Brasil PE; Pereira de Souza A; Hasslocher-Moreno AM; Xavier SS; Lambert Passos SR; de Fátima Ramos Moreira M; Santini de Oliveira M; Sperandio da Silva GM; Magalhães Saraiva R; Santos de Aguiar Cardoso C; de Sousa AS; Mediano MF; Bonecini de Almeida Mda G; da Cruz Moreira O; Britto C; de Araújo-Jorge TC
    Trials; 2014 Oct; 15():388. PubMed ID: 25284194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial.
    Murray MD; Young J; Hoke S; Tu W; Weiner M; Morrow D; Stroupe KT; Wu J; Clark D; Smith F; Gradus-Pizlo I; Weinberger M; Brater DC
    Ann Intern Med; 2007 May; 146(10):714-25. PubMed ID: 17502632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategy to recognize and initiate treatment of chronic heart failure in primary care (STRETCH): a cluster randomized trial.
    van Riet EE; Hoes AW; Limburg A; van der Hoeven H; Landman MA; Rutten FH
    BMC Cardiovasc Disord; 2014 Jan; 14():1. PubMed ID: 24400643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity?
    Santos-Gallego CG; Garcia-Ropero A; Mancini D; Pinney SP; Contreras JP; Fergus I; Abascal V; Moreno P; Atallah-Lajam F; Tamler R; Lala A; Sanz J; Fuster V; Badimon JJ
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):87-95. PubMed ID: 30675708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical assessment of Shenfu injection loading in the treatment of patients with exacerbation of chronic heart failure due to coronary heart disease: study protocol for a randomized controlled trial.
    Liu C; Hou Y; Wang X; Zhao Z; Liu Z; Zhai J; Mao J; Shang H
    Trials; 2015 May; 16():222. PubMed ID: 25994188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical assessment of complementary treatment with Qishen Yiqi dripping pills on ischemic heart failure: study protocol for a randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF).
    Hou YZ; Wang S; Zhao ZQ; Wang XL; Li B; Soh SB; Mao JY
    Trials; 2013 May; 14():138. PubMed ID: 23672353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy.
    Shen L; Ramires F; Martinez F; Bodanese LC; Echeverría LE; Gómez EA; Abraham WT; Dickstein K; Køber L; Packer M; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Jhund PS; Gimpelewicz CR; McMurray JJV;
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of pharmaceutical care for drug treatment adherence in patients with systemic lupus erythematosus in Rio de Janeiro, Brazil: study protocol for a randomized controlled trial.
    Oliveira-Santos M; Verani JF; Camacho LA; de Andrade CA; Ferrante-Silva R; Klumb EM
    Trials; 2016 Apr; 17():181. PubMed ID: 27038611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postdischarge community pharmacist-provided home services for patients after hospitalization for heart failure.
    Kalista T; Lemay V; Cohen L
    J Am Pharm Assoc (2003); 2015; 55(4):438-42. PubMed ID: 26161487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pharmaceutical care on the quality of life of patients with heart failure due to chronic Chagas disease: Randomized clinical trial.
    Chambela MDC; Mediano MFF; Carneiro FM; Ferreira RR; Waghabi MC; Mendes VG; Oliveira LS; de Holanda MT; de Sousa AS; da Costa AR; Xavier SS; da Silva GMS; Saraiva RM
    Br J Clin Pharmacol; 2020 Jan; 86(1):143-154. PubMed ID: 31659776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and design of the Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) study.
    Schnipper JL; Roumie CL; Cawthon C; Businger A; Dalal AK; Mugalla I; Eden S; Jacobson TA; Rask KJ; Vaccarino V; Gandhi TK; Bates DW; Johnson DC; Labonville S; Gregory D; Kripalani S;
    Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):212-9. PubMed ID: 20233982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
    Abdel-Salam Z; Rayan M; Saleh A; Abdel-Barr MG; Hussain M; Nammas W
    Cardiol J; 2015; 22(2):227-32. PubMed ID: 25179314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the six-minute walk test in patients with chronic heart failure associated with Chagas' disease and systemic arterial hypertension.
    Dourado KC; Bestetti RB; Cardinalli-Neto A; Cordeiro JA
    Rev Soc Bras Med Trop; 2010; 43(4):405-8. PubMed ID: 20802940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methodology of an ongoing, randomized, controlled trial to improve drug use for elderly patients with chronic heart failure.
    Murray MD; Young JM; Morrow DG; Weiner M; Tu W; Hoke SC; Clark DO; Stroupe KT; Wu J; Deer MM; Bruner-England TE; Sowinski KM; Smith FE; Oldridge NB; Gradus-Pizlo I; Murray LL; Brater DC; Weinberger M
    Am J Geriatr Pharmacother; 2004 Mar; 2(1):53-65. PubMed ID: 15555479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory muscle strength, the six-minute walk test and quality of life in Chagas cardiomyopathy.
    Vieira FC; de Melo Marinho PÉ; Brandão DC; Barbosae e Silva O
    Physiother Res Int; 2014 Mar; 19(1):8-15. PubMed ID: 23703777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized clinical trial of a postdischarge pharmaceutical care program vs regular follow-up in patients with heart failure.
    López Cabezas C; Falces Salvador C; Cubí Quadrada D; Arnau Bartés A; Ylla Boré M; Muro Perea N; Homs Peipoch E
    Farm Hosp; 2006; 30(6):328-42. PubMed ID: 17298190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.